Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Consensus
Buy3.71 / 5
7 ratings · Buy 5 · Hold 2
Price vs analyst targets
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
FY2029Dec '29
FY2030Dec '30
Revenue (B)
5.50
5.88
6.27
6.77
7.12
7.47
7.94
8.36
Growth YoY
+4.2%
+6.9%
+6.7%
+7.9%
+5.1%
+4.9%
+6.4%
+5.2%
High estimate
–
–
–
6.78
7.19
7.59
8.01
8.43
Low estimate
–
–
–
6.75
6.98
7.23
7.84
8.24
Analysts
–
–
–
8
8
9
4
4
EPS, adjusted
4.62
5.42
6.15
7.14
7.76
8.41
9.05
9.90
Growth YoY
−0.9%
+17.3%
+13.5%
+16.1%
+8.6%
+8.4%
+7.6%
+9.4%
High estimate
–
–
–
7.18
7.93
9.02
9.15
10.01
Low estimate
–
–
–
7.11
7.55
7.43
8.89
9.72
Analysts
–
–
–
6
6
5
1
1
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
7 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Morgan Stanley
James Faucette
Equal Weight · Apr 2026
Equal Weight
$85.00
$78.00
+9%
+8%
Oct 26
Needham
Mayank Tandon
Buy
Buy
$90.00
$95.00
−5%
+14%
Oct 23
DA Davidson
Peter Heckmann
Buy
Buy
$104.00
$96.00
+8%
+32%
Oct 22
Jefferies
–
Buy
Buy
$100.00
$83.00
+20%
+27%
Oct 21
UBS
Kevin McVeigh
Buy · Apr 2026
Buy
$101.00
$99.00
+2%
+28%
Sep 9
RBC Capital
–
Outperform
Outperform
$101.00
$92.00
+10%
+28%
Aug 31
JP Morgan
–
Neutral
Neutral
–
–
–
–
Jul 20
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data